No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Regeneron/Bayer Seek Japanese Approval of Aflibercept 8mg for Macular Oedema
On 9 May 2025, Bayer announced that it has submitted a marketing authorisation application to the Ministry of Health, Labour and Welfare in Japan for Eylea™/aflibercept 8mg for treating patients…